News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Conference News TCT 2022 Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL Yael L. Maxwell September 19, 2022
Presentation TCT 2022 TCT 758: Low Contrast Protected PCI Combining DES and DEB for the Treatment of Severely Calcified Left Main and Multivessel Disease in a High-Risk Patient Presenter: Ottavia Cozzi September 17, 2022
Presentation TCT 2022 Case #2: MVD With Low Ejection Fraction (High-Risk for CABG) Presenter: Arnold Seto September 17, 2022
News Conference News TCT 2022 Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus Yael L. Maxwell September 16, 2022
News Daily News Obesity May Boost Thrombotic Events in Contraceptive Users, Review Suggests L.A. McKeown September 16, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Daily News AI Tool Can Quantify CAC—and Associated CV Risk—From PET Yael L. Maxwell September 14, 2022
News Daily News Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes Michael O'Riordan September 13, 2022
News Daily News Higher Step Counts Equal Better CV Health: UK Biobank Caitlin E. Cox September 13, 2022
News Daily News Artificial Sweeteners Linked to CVD, Stroke in French Adults: Observational Study L.A. McKeown September 12, 2022
News Daily News Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive Michael O'Riordan September 09, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Conference News ESC 2022 GRACE 3.0: Women With NSTE ACS Get a Boost From Updated Score Caitlin E. Cox September 06, 2022
News Conference News ESC 2022 Routine Functional Testing Unnecessary After Stenting: POST-PCI Yael L. Maxwell September 06, 2022
News Daily News Monkeypox and the Heart: Acute Myocarditis Rare, With Good Outlook L.A. McKeown September 02, 2022
News Conference News ESC 2022 Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE Michael O'Riordan August 31, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Conference News ESC 2022 Less Death, Major Bleeding With Transradial Access: Meta-analysis Michael O'Riordan August 29, 2022
News Conference News ESC 2022 CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2 Todd Neale August 29, 2022